Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Handson Global Management (HGM) Ltd

HGM
NSE
52.95
1.57%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Handson Global Management (HGM) Ltd

HGM
NSE
52.95
1.57%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
67Cr
Close
Close Price
52.95
Industry
Industry
IT Enabled Services/Business Process Outsourcing
PE
Price To Earnings
160.45
PS
Price To Sales
1.27
Revenue
Revenue
52Cr
Rev Gr TTM
Revenue Growth TTM
146.56%
PAT Gr TTM
PAT Growth TTM
-88.41%
Peer Comparison
How does HGM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
HGM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
344446666141914
Growth YoY
Revenue Growth YoY%
18.122.344.032.136.456.030.145.429.0144.3239.6145.7
Expenses
ExpensesCr
334335554111817
Operating Profit
Operating ProfitCr
11111111121-2
OPM
OPM%
16.014.816.316.319.216.515.914.718.517.55.7-16.9
Other Income
Other IncomeCr
000000010111
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000011
PBT
PBTCr
11111111121-3
Tax
TaxCr
000000000110
PAT
PATCr
11111111121-3
Growth YoY
PAT Growth YoY%
35.5-68.3-54.728.6-3.650.09.6109.563.0121.8-37.5-336.4
NPM
NPM%
26.814.617.015.819.014.014.322.824.012.72.6-21.9
EPS
EPS
0.70.40.60.50.60.60.61.11.11.40.4-2.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
161515141111101012162252
Growth
Revenue Growth%
-7.61.9-11.9-22.54.0-12.04.219.933.839.4132.9
Expenses
ExpensesCr
181515131097810131950
Operating Profit
Operating ProfitCr
-200002222342
OPM
OPM%
-11.01.90.51.52.520.924.323.719.916.716.44.0
Other Income
Other IncomeCr
111411214222
Interest Expense
Interest ExpenseCr
011001000001
Depreciation
DepreciationCr
111111111112
PBT
PBTCr
-300312335452
Tax
TaxCr
001111111111
PAT
PATCr
-2-1-1201224340
Growth
PAT Growth%
75.1-58.6342.8-92.6725.665.2-10.6109.3-40.959.5-89.8
NPM
NPM%
-15.1-4.1-6.317.51.713.224.821.337.216.418.80.8
EPS
EPS
-124.2-220.1-116.11.90.10.52.01.73.62.13.40.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
131313131313131313131313
Reserves
ReservesCr
5663252270443121831710101111
Current Liabilities
Current LiabilitiesCr
1314134415141314121533
Non Current Liabilities
Non Current LiabilitiesCr
76529116237211121
Total Liabilities
Total LiabilitiesCr
598358521,011610521174538364078
Current Assets
Current AssetsCr
182017111111131016202342
Non Current Assets
Non Current AssetsCr
580338351,000599411043522161636
Total Assets
Total AssetsCr
598358521,011610521174538364078

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3-3202-3-1
Investing Cash Flow
Investing Cash FlowCr
1-1011242
Financing Cash Flow
Financing Cash FlowCr
-18-2-2-1-1-1
Net Cash Flow
Net Cash FlowCr
2-41-1300
Free Cash Flow
Free Cash FlowCr
3-3202-3-1
CFO To PAT
CFO To PAT%
1,524.9-180.469.8-5.248.9-129.2-29.7
CFO To EBITDA
CFO To EBITDA%
1,038.3-114.071.3-4.791.4-127.1-34.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
17698224290160297555537257
Price To Earnings
Price To Earnings
0.0-0.30.0121.6907.943.829.325.611.526.913.4
Price To Sales
Price To Sales
10.76.514.521.315.22.77.85.54.44.52.5
Price To Book
Price To Book
0.30.36.60.40.40.90.81.82.33.22.4
EV To EBITDA
EV To EBITDA
-98.8350.32,840.21,442.9605.312.030.422.418.923.113.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
-11.01.90.51.52.520.924.323.719.916.716.4
NPM
NPM%
-15.1-4.1-6.317.51.713.224.821.337.216.418.8
ROCE
ROCE%
-0.40.10.50.50.18.33.39.423.415.819.5
ROE
ROE%
-0.4-0.2-2.90.30.04.32.57.219.911.617.6
ROA
ROA%
-0.4-0.2-1.90.20.02.82.04.711.97.410.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
HandsOn Global Management (HGM) Limited (NSE: **HOVS**), formerly known as **HOV Services Limited**, is an Indian-listed enterprise undergoing a strategic transformation into a global **AI-driven healthcare technology and services platform**. The company operates a hybrid model, combining direct **IT and IT-Enabled Services (ITeS)** with a portfolio of strategic investments in the North American, APAC, and Middle East markets. --- ### **Strategic Pivot: The AI-First Healthcare Roadmap** HGM has aggressively reoriented its business model toward high-margin, tech-enabled healthcare delivery. The company’s vision is to integrate **Agentic AI workflow solutions** with specialized human expertise to address inefficiencies in global healthcare systems. * **Autonomous Medical Coding:** Through the acquisition of **Aidéo Technologies**, HGM has integrated the **Gemini™ AI Coding Platform**. This platform utilizes **Large Language Models (LLMs)** and **Natural Language Processing (NLP)** to automate medical coding, reducing human error and accelerating the billing cycle. * **Revenue Cycle Management (RCM):** The company is scaling its RCM vertical to provide end-to-end financial management for healthcare providers, focusing on improving collection rates and reducing claim denials. * **Healthcare Analytics & Ambient Listening:** HGM is developing virtual scribe services and clinical data management tools. These "ambient listening" technologies aim to improve provider efficiency by capturing patient-doctor interactions and converting them into structured clinical data. * **Interoperability Standards:** The company’s platforms are designed to be **HL7-compliant**, ensuring seamless integration with industry-standard **Electronic Health Records (EHR)** systems. --- ### **Corporate Structure & Global Footprint** HGM manages its international operations through a streamlined network of subsidiaries, primarily focused on the US market. | Entity | Relationship | Location | Role / Status | | :--- | :--- | :--- | :--- | | **HOVS LLC** | Wholly Owned Subsidiary | USA | **Material Subsidiary**; primary investment vehicle. | | **Healthcare Capital Holding LLC** | Wholly Owned Subsidiary | USA | Incorporated **May 2025**; dedicated to healthcare M&A. | | **Aidéo Technologies LLC** | Step-down Subsidiary | USA | Acquired **Sept 2025**; core AI autonomous coding arm. | | **HCI LLC** | Subsidiary | Cayman Islands | Established for operational harmonization and global scaling. | | **HOV Environment LLC** | Subsidiary | USA | **Discontinued operations**; slated for closure. | | **HOV Environment Solutions Pvt Ltd** | Step-down Subsidiary | India | Indian arm of the discontinued environment unit. | **Rationalization Initiatives:** * **Demerger:** In **August 2025**, the Board gave in-principle approval for the demerger of **HOVS LLC** (Delaware), pending final **RBI** approval. * **Entity Dissolution:** **HOVS Holdings Limited (Hong Kong)** was dissolved on **May 16, 2025**, as part of a broader effort to eliminate non-operational layers. --- ### **Investment Portfolio & Related Party Ecosystem** A significant portion of HGM’s value resides in its strategic holdings and long-term service contracts with affiliated global entities. * **Exela Technologies, Inc. (NASDAQ: XELA):** HGM holds a significant interest in Exela. In **November 2024**, HOVS LLC exchanged **55%** of its **Preferred A Stock** for **Common Stock**. However, as of **September 2025**, the fair value was marked at **Rs. Nil** following Exela's delisting from Nasdaq. * **High-Value Service Contracts (FY 2026-27 Targets):** * **HealthAxis Group LLC:** Services contract valued at **US$ 8.70 Million (₹ 78.30 Crore)**. * **XBP Europe Limited:** Services contract valued at **US$ 6 Million**. * **SourceHOV LLC & HOVG LLC:** Ongoing IT support and data entry contracts, valued at **₹ 50 Crore** in FY 2024-25. --- ### **Financial Performance & Capital Allocation** HGM maintains a **debt-free** standalone balance sheet, prioritizing liquidity and internal accruals to fund its inorganic growth strategy. **Consolidated Financial Highlights:** | Metric (INR Crore) | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | | **Total Income** | **17.85** | **15.87** | | **Profit from Continuing Operations** | **2.65** | **4.48** | | **Total Comprehensive Income/(Loss)** | **(2.40)** | **(12.66)** | | **Basic & Diluted EPS (Total)** | **₹ 2.13** | **₹ 3.63** | | **Debt to Total Equity Ratio** | **0.42** | **0.51** | * **Revenue Model:** Driven almost exclusively by the **export of services**. Foreign exchange earnings for FY 2023-24 were **₹ 16.12 Crore**. * **Asset Monetization:** The company generates steady cash flow from leasing building space in Pune, with future rental receivables of **₹ 4.61 Crore** projected through 2028. * **Capital Issuance:** In **November 2025**, the company issued **1,449,275 units** of **Class B Preferred Stock** (valued at **₹ 8.88 Crore**) to former members of Aidéo Technologies to facilitate business expansion. --- ### **Operational Infrastructure & Human Capital** * **Global Hubs:** Primary operational centers are located in **Pune, India** and **Las Vegas, USA**. * **Leadership:** The appointment of **Dr. Bhargav Thakkar** as **EVP - Healthcare Services** in **July 2025** signals a commitment to clinical-grade AI integration. * **Labor Compliance:** The company recognized a non-material provision in **December 2025** in anticipation of the new **Indian Labour Codes** (Code on Social Security, 2020). --- ### **Risk Management Framework** HGM operates under a structured risk mitigation strategy focused on the following pillars: * **Currency Volatility:** With a substantial portion of revenue in **USD** and costs in **INR**, the company manages an open exposure of approximately **$993,000 (₹ 82.78 Million)** through continuous market tracking. * **Credit & Default Risk:** Financial assets are strictly categorized; receivables are written off if payments are more than **one year past due**. * **Operational Inflation:** To combat rising **minimum wages** and **attrition**, HGM is shifting from labor-intensive BPO to **AI-led automation** to reduce manpower dependence. * **Cyber Security:** Mitigation includes **multi-layered anti-hacking systems**, regular **patch management**, and disaster recovery systems across global locations. * **Investment Volatility:** The company’s exposure to quoted shares (e.g., Exela) subjects the balance sheet to market fluctuations, managed via **Fair Value through Other Comprehensive Income (FVOCI)** accounting.